Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early tirofiban plus alteplase versus alteplase alone for acute ischemic stroke
ChiCTR-TRC-14004630Phase 4Completed
- Sponsor
- Army Specialized Medical Center
- Start
- Sep 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of tissue-plasminogen activator and tirofiban in ischemic stroke (2 arms), sponsored by Army Specialized Medical Center. Primary endpoints: NIHSS score and modified Rankin Scale score. Started Sep 2014; status: completed.
02
Drugs
tissue-plasminogen activatortirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-TRC-14004630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004630.